WuXi News
Most Popular WuXi Story
Novartis CEO plans to keep China R&D ops in-house
While Charles River's $1.6 billion deal to buy WuXi PharmaTech may have put the spotlight on China's growing role on the global contract research stage, Novartis' new CEO insists the pharma giant Read more...
Latest Headlines
- November 14, 2011
- July 30, 2010
- July 13, 2010
- April 29, 2010
- April 26, 2010
- April 13, 2009
- December 2, 2008
- October 20, 2008
- September 29, 2008
- January 10, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
